Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00676130 · ClinicalTrials.gov registry record · NA
Study of New Antibiotic Regimen for the Treatment of Uncomplicated Cellulitis in Emergency Department Patients
A NA study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 153
- Enrollment target
NCT00676130 is a NA study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 153 participants.
The verdict
NCT00676130, a NA study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 153 participants
- Enrollment target
Study Summary
The primary aim of this study is to quantify the effectiveness of Bactrim as additional therapy for the treatment of uncomplicated cellulitis in adults, by comparing: standard therapy plus Bactrim, versus standard therapy plus placebo. The primary hypothesis of this study is that, in light of increasing CA-MRSA prevalence, subjects treated with standard therapy plus Bactrim will have higher cure rates than those treated with standard therapy plus placebo.
Interventions
- DRUG Cephalexin
- DRUG trimethoprim-sulfamethoxazole
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 153 participants |
| Start Date | 2007-05 |
| Est. Completion | 2012-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00676130
The ClinicalTrials.gov registry entry for NCT00676130 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 153 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cephalexin is the first listed.
NCT00676130 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00676130 about?
NCT00676130 is a clinical study titled "Study of New Antibiotic Regimen for the Treatment of Uncomplicated Cellulitis in Emergency Department Patients". The primary aim of this study is to quantify the effectiveness of Bactrim as additional therapy for the treatment of uncomplicated cellulitis in adults, by comparing: standard therapy plus Bactrim, versus standard therapy plus placebo. The primary hypothesis of this study is that, in light of incre...
What is the current status of trial NCT00676130?
This trial is currently completed. It is a NA study. The enrollment target is 153 participants. The study started on 2007-05. Estimated completion is 2012-05.
What interventions are being tested in trial NCT00676130?
The interventions under investigation include: Cephalexin (DRUG), trimethoprim-sulfamethoxazole (DRUG).
Who is sponsoring clinical trial NCT00676130?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.